StockData
Illumina, Inc. logo

Illumina, Inc. (ILMN) stock

ILMNNasdaqLaboratory Analytical InstrumentsFiscal year ends January 3
Financials through Q3 FY2026, quarter ended Sep 27, 2026Last filing: 10-Q on Oct 30, 2026Score 14/3011% above fair value
$200.66−9.35 (-4.45%)

Close on Nov 19, 2026Market cap $30.34BP/E 34.4Yield –

Illumina gross profit

Gross profit is revenue minus the direct cost of the goods and services sold.

Illumina's gross profit for the twelve months ending Sep 27, 2026 was $3.08B, up 8.5% year over year. For fiscal 2025 it was $2.87B, up 0.3% from the year before. Over ten years it grew 6.4% a year on average. The highest annual figure on record is $3.15B in fiscal 2021.

Annual gross profit

PeriodPeriod endValueChange
FY2025Dec 28, 2025$2.87B+0.3%
FY2024Dec 29, 2024$2.86B+4.3%
FY2023Dec 31, 2023$2.74B-7.7%
FY2022Jan 1, 2023$2.97B-5.8%
FY2021Jan 2, 2022$3.15B+43.2%
FY2020Jan 3, 2021$2.20B-10.7%
FY2019Dec 29, 2019$2.47B+7.3%
FY2018Dec 30, 2018$2.30B+26.0%
FY2017Dec 31, 2017$1.83B+9.6%
FY2016Jan 1, 2017$1.67B+7.6%
FY2015Jan 3, 2016$1.55B+19.4%
FY2014Dec 28, 2014$1.30B+42.3%
FY2013Dec 29, 2013$911.89M+17.9%
FY2012Dec 30, 2012$773.53M+9.1%
FY2011Jan 1, 2012$709.10M+17.9%
FY2010Jan 2, 2011$601.54M+32.5%
FY2009Jan 3, 2010$453.88M+28.5%
FY2008Dec 28, 2008$353.09M–

Quarterly gross profit

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 27, 2026$830.00M+13.2%
Q2 FY2026Jun 28, 2026$770.00M+10.8%
Q1 FY2026Mar 29, 2026$721.00M+5.6%
Q4 FY2025Dec 28, 2025$759.00M+4.3%
Q3 FY2025Sep 28, 2025$733.00M-1.6%
Q2 FY2025Jun 29, 2025$695.00M-3.6%
Q1 FY2025Mar 30, 2025$683.00M+2.4%
Q4 FY2024Dec 29, 2024$728.00M+8.0%
Q3 FY2024Sep 29, 2024$745.00M+8.9%
Q2 FY2024Jun 30, 2024$721.00M-1.5%
Q1 FY2024Mar 31, 2024$667.00M+1.8%
Q4 FY2023Dec 31, 2023$674.00M+0.3%
Q3 FY2023Oct 1, 2023$684.00M-4.6%
Q2 FY2023Jul 2, 2023$732.00M-4.6%
Q1 FY2023Apr 2, 2023$655.00M-19.6%
Q4 FY2022Jan 1, 2023$672.00M-17.7%
Q3 FY2022Oct 2, 2022$717.00M-6.9%
Q2 FY2022Jul 3, 2022$767.00M-4.4%
Q1 FY2022Apr 3, 2022$815.00M+6.7%
Q4 FY2021Jan 2, 2022$817.00M+29.7%
Q3 FY2021Oct 3, 2021$770.00M+46.4%
Q2 FY2021Jul 4, 2021$802.00M+87.4%
Q1 FY2021Apr 4, 2021$764.00M+23.4%
Q4 FY2020Jan 3, 2021$630.00M-4.8%
Q3 FY2020Sep 27, 2020$526.00M-18.8%
Q2 FY2020Jun 28, 2020$428.00M-25.3%
Q1 FY2020Mar 29, 2020$619.00M+6.0%
Q4 FY2019Dec 29, 2019$662.00M+12.2%
Q3 FY2019Sep 29, 2019$648.00M+8.5%
Q2 FY2019Jun 30, 2019$573.00M-0.3%
Q1 FY2019Mar 31, 2019$584.00M+8.6%
Q4 FY2018Dec 30, 2018$590.00M+8.9%
Q3 FY2018Sep 30, 2018$597.00M+23.9%
Q2 FY2018Jul 1, 2018$575.00M+32.5%
Q1 FY2018Apr 1, 2018$538.00M+46.2%
Q4 FY2017Dec 31, 2017$542.00M+29.4%
Q3 FY2017Oct 1, 2017$482.00M–
Q2 FY2017Jul 2, 2017$434.00M–
Q1 FY2017Apr 2, 2017$368.00M–
Q4 FY2016Jan 1, 2017$419.00M–

More Illumina figures

See a number that looks wrong?